Pulmonary Hypertension (PH) Suspended Phase 2 Trials for Ambrisentan (DB06403)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01332331Efficacy and Safety of Ambrisentan in Children 8-18yrsTreatment